These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8578234)

  • 1. Cholesterol gallstone formation in man and potential treatments of the gallbladder motility defect.
    Portincasa P; Stolk MF; van Erpecum KJ; Palasciano G; van Berge-Henegouwen GP
    Scand J Gastroenterol Suppl; 1995; 212():63-78. PubMed ID: 8578234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisapride improves gallbladder contractility and bile lipid composition in an animal model of gallstone disease.
    Xu QW; Shaffer EA
    Gastroenterology; 1993 Oct; 105(4):1184-91. PubMed ID: 8405865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for
    Wang HH; Portincasa P; Liu M; Tso P; Wang DQ
    Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33260332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallbladder emptying in vivo, bile composition, and nucleation of cholesterol crystals in patients with cholesterol gallstones.
    Stolk MF; van Erpecum KJ; Renooij W; Portincasa P; van de Heijning BJ; vanBerge-Henegouwen GP
    Gastroenterology; 1995 Jun; 108(6):1882-8. PubMed ID: 7768394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on the pathogenesis and treatment of cholesterol gallstones.
    Portincasa P; van de Meeberg P; van Erpecum KJ; Palasciano G; VanBerge-Henegouwen GP
    Scand J Gastroenterol Suppl; 1997; 223():60-9. PubMed ID: 9200309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired gallbladder mucosal function in aged gallstone patients suppresses gallstone recurrence after successful extracorporeal shockwave lithotripsy.
    Tazuma S; Nishioka T; Ochi H; Hyogo H; Sunami Y; Nakai K; Tsuboi K; Asamoto Y; Sakomoto M; Numata Y; Kanno K; Yamaguchi A; Kobuke T; Komichi D; Nonaka Y; Chayama K
    J Gastroenterol Hepatol; 2003 Feb; 18(2):157-61. PubMed ID: 12542599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisapride improves gallbladder emptying and bile lipid composition in patients with gallstones.
    Dhiman RK; Reddi R; Sharma A; Singh R; Kohli KK; Gupta S; Suri S; Chawla Y
    J Gastroenterol Hepatol; 2001 Jul; 16(7):816-20. PubMed ID: 11446892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: defects in gall-bladder motor function--role in gallstone formation and recurrence.
    Pauletzki J; Paumgartner G
    Aliment Pharmacol Ther; 2000 May; 14 Suppl 2():32-4. PubMed ID: 10903000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic factors in early recurrence of cholesterol gallstones.
    Berr F; Mayer M; Sackmann MF; Sauerbruch T; Holl J; Paumgartner G
    Gastroenterology; 1994 Jan; 106(1):215-24. PubMed ID: 8276184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol gallstone disease: focusing on the role of gallbladder.
    Chen Y; Kong J; Wu S
    Lab Invest; 2015 Feb; 95(2):124-31. PubMed ID: 25502177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol gallstone formation: supersaturation, nucleation and gallbladder motility.
    Duellberg SH; Werneck-Silva AL; Sipahy AM; Damião AO; Laudanna AA
    Rev Hosp Clin Fac Med Sao Paulo; 1996; 51(5):198-202. PubMed ID: 9216100
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of gallbladder mucin in pathophysiology of gallstones.
    LaMont JT; Smith BF; Moore JR
    Hepatology; 1984; 4(5 Suppl):51S-56S. PubMed ID: 6546237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathobiology of cholesterol gallstone disease: from equilibrium ternary phase diagram to agents preventing cholesterol crystallization and stone formation.
    Portincasa P; Moschetta A; Calamita G; Margari A; Palasciano G
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Mar; 3(1):67-81. PubMed ID: 12570727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile lithogenicity and gallbladder emptying in patients with microlithiasis: effect of bile acid therapy.
    Sharma BC; Agarwal DK; Dhiman RK; Baijal SS; Choudhuri G; Saraswat VA
    Gastroenterology; 1998 Jul; 115(1):124-8. PubMed ID: 9649467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones.
    Portincasa P; Di Ciaula A; Vendemiale G; Palmieri V; Moschetta A; Vanberge-Henegouwen GP; Palasciano G
    Eur J Clin Invest; 2000 Apr; 30(4):317-24. PubMed ID: 10759880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence.
    Pauletzki J; Althaus R; Holl J; Sackmann M; Paumgartner G
    Gastroenterology; 1996 Sep; 111(3):765-71. PubMed ID: 8780583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of gallbladder mucus in the pathogenesis of cholesterol gallstones.
    Doty JE; Pitt HA; Kuchenbecker SL; Porter-Fink V; DenBesten LW
    Am J Surg; 1983 Jan; 145(1):54-61. PubMed ID: 6849496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E4 genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after extracorporeal shock-wave lithotripsy.
    Portincasa P; van Erpecum KJ; van De Meeberg PC; Dallinga-Thie GM; de Bruin TW; van Berge-Henegouwen GP
    Hepatology; 1996 Sep; 24(3):580-7. PubMed ID: 8781328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs affecting biliary lipid secretion and gallbladder motility: their potential role in gallstone treatment and prevention.
    vanBerge-Henegouwen GP; Venneman NG; van Erpecum KJ; Portincasa P
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Jun; 5(2):185-91. PubMed ID: 16089351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallstones during octreotide therapy.
    Dowling RH; Hussaini SH; Murphy GM; Besser GM; Wass JA
    Metabolism; 1992 Sep; 41(9 Suppl 2):22-33. PubMed ID: 1355588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.